ABL’s Bispecific Antibody For Parkinson's Lands In Sanofi’s Hands

$1bn Deal A CNS Leg Up For French Firm?

 
• By Jung Won Shin
  
partnership
Hefty Upfront, Near Term Milestones For ABL Bio • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business